Ningxia Zhongke expects 2023 net loss to widen

Summary: Zhongke Biotech posted forecasts for 2023, with a widening net loss in the range of -USD70.36 million (-RMB500 million) to -USD49.25 million (-RMB350 million) , down by 147.38% to 253.40% YoY.On 30 Jan., Ningxia Zhongke Biotechnology Co., Lt...

Bio-based Material Quarterly Newsletter Q1 2024

www.cnchemicals.com